Evaluation of Two Different Grafting Techniques After Mandibular Impacted Third Molar Surgery

NCT04366635 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2020-05-06

No results posted yet for this study

Summary

This study evaluates the effectiveness of using Mineralized Plasmatic Matrix and β-tricalcium phosphate that placed to extraction socket as a graft material in terms of periodontal damage occurred in the distal aspect of the second molar after mandibular impacted third molar surgery.

Conditions

  • Periodontal Pocket
  • Impacted Third Molar Tooth
  • Impacted Teeth With Abnormal Position

Interventions

PROCEDURE

Impacted third molar surgery

Under local anesthesia, flap will be raised and mesioangular or horizontal impacted third molar tooth will be removed with routine technique. And then extraction socket will be irrigated with salin and will be primarily closed.

PROCEDURE

Application of mineralised plasmatic matrix

After extraction of impacted third molar tooth, Mineralized Plasmatic Matrix will be placed to the socket as a graft material and will be covered with Platelet Rich Fibrin membrane. Then wound will be primarily closed.

PROCEDURE

Application of β-tricalcium phosphate

After extraction of impacted third molar tooth, β-tricalcium phosphate will be placed to the socket as a graft material and will be covered with Platelet Rich Fibrin membrane. Then wound will be primarily closed.

Sponsors & Collaborators

  • Konya Necmettin Erbakan Üniversitesi

    lead OTHER

Principal Investigators

  • Kubilay Işık · Consultant

  • Ali Kılınç · Care Provider

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-27
Primary Completion
2020-05-20
Completion
2020-08-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04366635 on ClinicalTrials.gov